BioSpace News Archive

Fact.MR – A Market Research and Competitive Intelligence Provider: As per latest Fact.MR analysis, the global syringes market is set to register a CAGR of 7.8% in 2021, reaching a valuation of US$ 16.5 Bn by 2021 end.

ANI Pharmaceuticals, Inc. announced the launch of Nebivolol Tablets, 2.5 mg, 5 mg, 10 mg, and 20 mg.

Vicore Pharma Holding AB, a rare disease pharmaceutical company developing innovative medicines for severe lung disorders announces the dosing of the first patients in the company’s global phase 3 trial of C21 in COVID-19.

111, Inc. today announced that Senior Vice President, Investor Relations and Business Development, Tiffany ZhuGe , will present an update on the Company’s business and host one-on-one meetings with investors at the Cantor Global Healthcare Conference, which is being held virtually on September 27-30, 2021.

Aesther Healthcare Acquisition Corp. (Nasdaq: AEHAU) (the “Company”) announced today the closing of its initial public offering of 10,000,000 units at $10.00 per unit.

Ocugen, Inc. announced the Compensation Committee of the Board of Directors of Ocugen approved the grant of stock options to purchase an aggregate of 137,250 shares of its common stock and restricted stock units covering an aggregate of 23,000 shares of common stock to seven hired employees.

Pfizer Inc. and BioNTech SE announced that the U.S. Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee voted unanimously to recommend the FDA grant Emergency Use Authorization for a booster dose of COMIRNATY® in individuals 65 years of age and older and individuals at high risk of severe COVID-19.

Biophytis SA publishes its interim financial report for the first half of 2021 and provides updates on key operational developments and financing transactions.

NeoDynamics has received orders from four high profile clinics in Germany and Switzerland for its novel biopsy system NeoNavia.

Zhongchao Inc. today announced the launch of its multidisciplinary treatment (“MDT”) clinical thinking training platform for hematology (“Hematology MDT Platform”).